当前位置: X-MOL 学术J. Natl. Cancer Inst. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Risk stratification of prostate cancer through quantitative assessment of PTEN loss (qPTEN).
Journal of the National Cancer Institute ( IF 9.9 ) Pub Date : 2020-03-04 , DOI: 10.1093/jnci/djaa032
Tamara Jamaspishvili 1, 2 , Palak G Patel 1, 2 , Yi Niu 3, 4 , Thiago Vidotto 1, 5, 6 , Isabelle Caven 1, 2 , Rachel Livergant 1, 2 , Winnie Fu 1, 2 , Atsunari Kawashima 1, 2, 7 , Nathan How 1, 2 , John B Okello 1, 2 , Liana B Guedes 8 , Veronique Ouellet 9 , Clarissa Picanço 6 , Madhuri Koti 1, 5, 10 , Rodolfo B Reis 11 , Fred Saad 9, 12 , Anne-Marie Mes-Masson 9, 13 , Tamara L Lotan 8, 14 , Jeremy A Squire 6 , Yingwei P Peng 3, 15, 16 , D Robert Siemens 10 , David M Berman 1, 2, 5
Affiliation  

Phosphatase and tensin homolog (PTEN) loss has long been associated with adverse findings in early prostate cancer. Studies to date have yet to employ quantitative methods (qPTEN) for measuring of prognostically relevant amounts of PTEN loss in postsurgical settings and demonstrate its clinical application.

中文翻译:

通过定量评估PTEN丢失(qPTEN)对前列腺癌进行风险分层。

长期以来,磷酸酶和张力蛋白同源物(PTEN)的丢失与早期前列腺癌的不良发现有关。迄今为止的研究尚未采用定量方法(qPTEN)来测量术后环境中PTEN丢失的预后相关量,并证明其临床应用。
更新日期:2020-03-04
down
wechat
bug